ŠÅŒì‚Ç‚Á‚ƍ‡Œ¾—t  „ ŠÅŒìEˆã—×pŒê@—ªŒêW  „ y‚lz
ŒfÚ‚µ‚Ä—~‚µ‚¢—ªŒê‚ª‚ ‚è‚Ü‚µ‚½‚ç
‚±‚¿‚ç‚Ü‚Å‚²˜A—‚­‚¾‚³‚¢B
Google
 
ŠÅŒìEˆã—×pŒê@—ªŒêW@y‚lz
—ªŒê “ú–{Œê‚̈Ӗ¡ ƒXƒyƒ‹ “Ç‚Ý•û
‚l ˆ«« ‚l‚‚Œ‚‰‚‡‚Ž‚‚Ž‚” ƒ}ƒŠƒOƒiƒ“ƒg
@ ƒ‚ƒ‹”Z“x ‚l‚‚Œ‚‚’@‚b‚‚Ž‚ƒ‚…‚Ž‚”‚’‚‚”‚‰‚‚Ž@ @
MA ‰^“®«Ž¸ŒêÇ Motor Aphasia @
@ ‘m–X•Ù•Â½Ç Mitral Atresia @
@ ¸_”N—î Mental Age @
MAAS ‰ß“x—r…‹zˆøÇŒóŒQ Massive Mmnion Aspiration Syndrome @
MAC Å¬”x–E“à”Z“x Minimum Alveolar Concentration @
@ Å¬–ƒŒ”Z“x Minimun Anesthetic Concentration @
@ Å‘å‹–—e”Z“x Maximum Allowable Cincentration @
@ ‘m–X•Ù—֐ΊD‰» Mitral Annulus Calcification @
MAD Å‘å‹–—eü—Ê Maximum Allowable Dose @
MAHC ˆ««Žîᇐ”º«‚ƒJƒ‹ƒVƒEƒ€ŒŒÇ Malignancy Associated Hypercalcemia @
MAP ‘m–X•Ù—ÖŒ`¬p Mitral Annuloplasty @
@ ƒqƒgÔŒŒ‹…”ZŒú‰t Mannitol-Adenine-Phospate solution @
MAS ‘Ù•Ö‹zˆøÇŒóŒQ Mecomium Aspiration Symdrome @
@ ‘å—Ê‹zˆøÇŒóŒQ Massive Aspiration Syndrome ƒ}ƒbƒVƒu@ƒAƒXƒsƒŒƒCƒVƒ‡ƒ“@ƒVƒ“ƒhƒ[ƒ€
MAT ‘½Œ¹«S–[«•p–¬ Multifocal Attrial Tachycardia ƒ}ƒ‹ƒ`ƒtƒH[ƒJƒ‹@ƒAƒgƒŠƒAƒ‹@ƒ^ƒLƒAƒ‹ƒfƒBƒA
MBAMb ƒ~ƒIƒOƒƒrƒ“ Myoglobin ƒ~ƒIƒOƒƒrƒ“
MBC Å‘劷‹C—Ê Maximum Breathing Capacity ƒ}ƒLƒVƒ}ƒ€@ƒuƒŠ[ƒWƒ“ƒO@ƒLƒƒƒpƒVƒeƒB
@ Å‘åäNã÷—e—Ê Maximum Bladder Capacity @
MBD ”÷×”]‘¹ Minor Brain Damage ƒ}ƒCƒi[@ƒuƒŒƒCƒ“@ƒ_ƒ[ƒW
@ ”÷×”]áŠQ Minimal Brain Dysfunction @
MBPAmBP •½‹ÏŒŒˆ³ Mean Blood Pressure ƒ~[ƒ“@ƒuƒ‰ƒbƒh@ƒvƒŒƒbƒVƒƒ[
MCA ’†‘å”]“®–¬ Middle Cerebral Artery @
McB ƒ}ƒbƒNƒo[ƒjˆ³’É“_ McBurney's (Point) ƒ}ƒbƒNƒo[ƒCƒY@ƒ|ƒCƒ“ƒg
MCC •½‹ÏÔŒŒ‹…ƒwƒ‚ƒOƒƒrƒ“”Z“x Mean Corouscular Hemoglobin Concentration @
MCFG @ Micafungin ƒ~ƒJƒtƒ@ƒ“ƒMƒ“Aƒtƒ@ƒ“ƒK[ƒh
MC Flap ‹Ø”ç•Ù Musculocutaneous Flap @
MCHC •½‹ÏÔŒŒ‹…ƒwƒ‚ƒOƒƒrƒ“”Z“x Mean Corouscular Hemoglobin Concentration @
MCLS ‹}«”畆”S–ŒƒŠƒ“ƒpßÇŒóŒQEìè•a Mucocutaneous Lymph Node Syndrome @
MCT •½‹ÏzŠÂŽžŠÔ Mean Circulation Time ƒ~[ƒ“@ƒT[ƒLƒ…ƒŒƒCƒVƒ‡ƒ“@ƒ^ƒCƒ€
MCZ @ Miconazole ƒ~ƒRƒiƒ][ƒ‹AƒtƒƒŠ[ƒhAƒtƒƒŠ[ƒh]DAƒtƒƒŠ[ƒh]F
MD ˆãŽtEˆãŠw”ŽŽm Medical Doctor ƒƒfƒBƒJƒ‹ƒhƒNƒ^[
@ çN‚¤‚•a Manic Depressive @
MD50 ‚T‚O“—LŒø—Ê Mean Effective Dose ƒ~[ƒ“@ƒGƒtƒFƒNƒeƒBƒu@ƒh[ƒY
MDC Å‘åŠgŽU”\—Í Maximal Diffusing Capacity ƒ}ƒLƒVƒ}ƒ‹@ƒfƒBƒtƒ…[ƒWƒ“ƒO@ƒLƒƒƒpƒVƒeƒB
MDI çN‚¤‚•a Manic-Depressive Illness @
@ ’è—Ê•¬–¶‹z“üŠí Metered-Dose Inhaler @
MDM @ Midecamycin ƒ~ƒJƒfƒ}ƒCƒVƒ“Aƒƒfƒ}ƒCƒVƒ“Aƒ~ƒIƒJƒ}ƒCƒVƒ“
MDR ˆê“úÅ’á•K—v—Ê Minimum Daily Requirement @
@ ‘½Ü‘ϐ« Multiple Drug Resistance @
MDRTB ‘½Ü‘ϐ«Œ‹Šj Multiple Drug Resistance Tuberculosis @
MED Å¬—LŒø—Ê Minimum Effective Dose ƒ~ƒjƒ}ƒ€@ƒGƒtƒFƒNƒeƒBƒu@ƒh[ƒY
MEF Å‘åŒÄ‹C—¬—Ê Maximal Expiratory Flow ƒ}ƒLƒVƒ}ƒ‹@ƒGƒNƒXƒsƒ‰ƒgƒŠ[@ƒtƒ[
MEFR Å‘åŒÄ‹C‘¬“x Maximal Expiratory Flow Rate ƒ}ƒLƒVƒ}ƒ‹@ƒGƒNƒXƒsƒ‰ƒgƒŠ[@ƒtƒ[@ƒŒƒCƒg
MEFV Å‘å“w—͐«ŒÄ‹C—¬—Ê Maimal Expiratoru Flow Volume ƒ}ƒLƒVƒ}ƒ‹@ƒGƒNƒXƒsƒ‰ƒg‚è[@ƒtƒ[ƒ{ƒŠƒ…[ƒ€
MEG ”]Ž¥} Magnetoencepalogram @
MEP Å‘åŒÄ‹Cˆ³ Maximal@Expiratory@Pressure ƒ}ƒLƒVƒ}ƒ‹@ƒGƒNƒXƒsƒ‰ƒg‚è[@ƒvƒŒƒbƒVƒƒ[
MEPM@ @ Meropenem ƒƒƒyƒlƒ€Aƒƒƒyƒ“
MES Å‘åŠá‹…‘¬“x Maximal@Eyes@Speed ƒ}ƒLƒVƒ}ƒ‹@ƒAƒCƒY@ƒXƒs[ƒh
meta Šà‚Ì“]ˆÊ MEtastasis ƒƒ^ƒXƒ^ƒVƒX
METT Å‘啉‰×ŽŽŒ± Maximum Exercise Tolerance Test @
MF ƒ}ƒCƒgƒ}ƒCƒVƒ“‚b‚ƃtƒ‹ƒIƒƒEƒ‰ƒVƒ‹‚Ì•¹—p‰»Šw—Ö@ Mitomycin Fluorouracil ƒ}ƒCƒgƒ}ƒCƒVƒ“@ƒtƒ‹ƒIƒƒEƒ‰ƒVƒ‹
MFD Å¬’vŽ€—Ê Minimum Fetal Dose @
MFLX @ Moxilfloxacin ƒ‚ƒLƒVƒtƒƒLƒTƒVƒ“AƒAƒxƒƒbƒNƒX
MFP zŠÂŒn•½‹Ï[–žˆ³ Mean Circulatory Filling Pressure @
MFT ‰^“®‹@”\ƒeƒXƒg Motor Function Test @
MG dÇ‹Ø–³—ÍÇ Myasthenia Gravis @
Mg ƒ}ƒOƒlƒVƒEƒ€ Magnesium @
MGN –Œ«Ž…‹…‘̐t‰Š Membranous Glomerulonephritis @
MH ˆ««‚‘̉·ÇAˆ««‚”MÇ Malignant Hyperthermia @
MHV ’†ŠÌÃ–¬ Middle Hepatic Vein @
MI S‹Ø[Ç Myocardial Infarction @
@ ¸_Ž¾Š³ Mental Illness @
@ ‘m–X•Ù•Â½•s‘S(Ç) Mitral Insufficiency @
MICU ƒhƒNƒ^[ƒJ[ Mobile Intensive Care Unit @
MID ‘½”­[Ç«’s•ð Multi-Infarct-Dementia @
MIF Å‘å‹z‹C—¬—Ê Maximum Inspiratory Flow @
MINO @ Minocycline ƒ~ƒmƒTƒCƒNƒŠƒ“Aƒ~ƒmƒ}ƒCƒVƒ“
MIP Å‘å‹z‹Cˆ³ Maximum Inspiratory Pressure @
ML ˆ««ƒŠƒ“ƒpŽî Malignant Lymphoma @
@ ”x’†—t Middle Lobe of Lung @
MLD Å¬’vŽ€—ʁAÅ’á’vŽ€—Ê Minimum Lethal Dose @
@ ’†ŠÔ’vŽ€—Ê Mean(median)Lethal Dose @
MLG Ò‘o‘¢‰e(–@) Myelography @
MLNS ‹}«”畆”S–ŒƒŠƒ“ƒpßÇŒóŒQAìè•a (acute)Mucocutaneous Lymphnode Syndrome @
MM ˆ««•FŽî Malignant Melanoma @
@ ‘½”­«œ‘Žî Multiple Myeloma @
MMC ƒ}ƒCƒgƒ}ƒCƒVƒ“‚b Mitomycin C @
MM(E)F Å‘å’†ŠÔŒÄ‹C—¬—Ê Maximal Midexpiratory Flow @
MMFR Å‘å’†ŠÔŒÄ‹C—¬‘¬ Maximum Midexpiratory Flow Rate @
MMK “û‚ª‚ñ Mammakrebs ƒ}ƒ“ƒ}ƒNƒŒ[ƒuƒX
MMR –ƒ]A‚¨‚½‚Ó‚­‚©‚º(—¬s«Ž¨‰º‘B‰Š)A•—]‚̍¬‡ƒƒNƒ`ƒ“ Measles-Mumps-Rubella(vaccine) @
MMST ŠÈˆÕ’m”\ŽŽŒ± Mini-Mental State Test @
MMT “kŽè‹Ø—̓eƒXƒg Manual Muscle Testing @
MMV ‹­§•ªŽžŠ·‹C—Ê Mandatory Minute Volume @
MOD ¬lŒ^“œ”A•a Maturity Onset Diabetes Mellitus @
MODS ‘½‘ŸŠí•s‘SÇŒóŒQ Multiple Organ Dysfunction Syndrome @
MODY ¬Ž™¬lŒ^“œ”A•a Maturity Onset Diabetes Mellitus og Young People @
MOF ‘½‘ŸŠí•s‘S Multiple Organ Failure @
MOI Š´õ‘½d“x Mutiplicity of Infection @
mol ƒ‚ƒ‹ Mole @
Mole –EóŠï‘Ù @ @
mortal Ž€–S—¦ Mortality @
MP ’†ŽèŽwßŠÔiŠÖßj Metacarpophalangeal (Joint) @
MPA Žå”x“®–¬ Main Pulmonary Artery @
mPAP •½‹Ï”x“®–¬ˆ³ Mean Pulmonary Arterial Pressure @
MPC Å‘å‹–—e”Z“x Maximum Permissible Concentration @
MPI S‹ØŒŒ—¬‘œ(ƒCƒ[ƒWƒ“ƒO) Myocardial Perfusion Imaging @
MEpn ƒ}ƒCƒRƒvƒ‰ƒYƒ}”x‰Š Mycoplasma Pneumonia @
MPV –å–¬–{Š² Main Portal Vein @
MR ˆã—Ïî•ñ’S“–ŽÒ Medical Representative @
@ ¸_(”­’B)’x‘Ø Mental Retardation @
@ ‘m–X•Ù‹t—¬(Ç) Mitral Regurgitation @
@ –ƒ]E•—]ƒƒNƒ`ƒ“ Measles-Rubella(vacine) @
MRA ˆ««ŠÖßƒŠƒEƒ}ƒ` Malignant rheumatoid Arthritis @
@ Ž¥‹C‹¤–ÂŒŒŠÇ‘¢‰e(–@) Magnetic Resonance Angiography @
MRDM ‰h—{áŠQŠÖ˜A“œ”A•a Malnutrition Related Diabetes Mellitus @
MRF ’†”]–Ô—l‘Ì Mesencephalic Reticular Formation @
MRI Ž¥‹C‹¤–ÂŽB‘œ–@ Magnetic Resonance Imaging @
MRM ‚¨‚½‚Ó‚­‚©‚º(—¬s«Ž¨‰º‘B‰Š)A•—]A–ƒ]3Ží¬‡ƒƒNƒ`ƒ“ Mumps.Rubella and Measles(vaccine) @
mRNA “`—߃Šƒ{ŠjŽ_AƒƒbƒZƒ“ƒWƒƒ[RNA Messenger Ribonucleic Acid @
mRNP “`—߃Šƒ{Šj’`”’AƒƒbƒZƒ“ƒWƒƒ[RNP Messenger Ribonucleoprotein @
MRS(A) ƒƒ`ƒVƒŠƒ“‘ϐ«‰©FƒuƒhƒE‹…‹Û Methicillin-Resistant Staphylococcus (Aureus) @
MRV •ªŽžŒÄ‹z—Ê Minute Respiratory Volume @
MS ¸_ó‘Ô Mental Status @
@ ‘m–X•Ù‹·ó(Ç) Mitral Stenosis @
@ ‘½”­«d‰»Ç Multiple Sclerosis @
@ ƒƒjƒG[ƒ‹ÇŒóŒQ Meniere's Syndrome @
MSI ‘m–X•Ù‹·óŒ“•Â½•s‘SÇ Mitral Stenoinsufficiency @
MSR ‘m–X•Ù‹·óŒ“•Â½•s‘SÇ Mitral Stenoregurgitation @
MSSA ƒƒ`ƒVƒŠƒ“Š´Žó«‰©FƒuƒhƒE‹…‹Û Methicillin-Sensitive Staphylococcus Aureus @
MST 50“¶‘¶ŠúŠÔ Median Survival Time @
MSUD ƒ[ƒvƒ‹ƒVƒƒbƒv”AÇ Maple Syrup Urine Disease @
MSVR Å‘åˆÝ‰t•ª”å—Ê Maximal Secretion Volume Rate @
MSW ˆã—Ã\[ƒVƒƒƒ‹ƒ[ƒJ[ Medical Social Worker @
MT •ê‘Ì”À‘— Maternal Transport @
MTR Å‘åƒgƒ‰ƒbƒLƒ“ƒOƒ‚[ƒh Maximum Tracking Rate @
MTX ƒƒgƒgƒŒƒLƒT[ƒg Methotrexate @
MV ‹@ŠB“IlHŠ·‹C Mechanical Ventilation @
@ ‘m–X•Ù Mitral Valve @
@ •ªŽžŠ·‹C—Ê Minute Ventilation @
MVA ‘m–X•Ù•ÙŒû–ÊÏ Mitral Valve Area @
MVD ”÷¬ŒŒŠÇ_ŒoŒ¸ˆ³–@ Microvascular Decompression @
MVO SŽº’†•”•ÂÇÇ Midventricular Obstruction @
MVP ‘m–X•Ùˆí’E(Ç) Mitral Valve Prolapse @
@ ‘m–X•ÙŒ`¬(p) Mitral Valvuloplasty @
MVR ‘m–X•Ù’uŠ·(p) Mitral Valve Replacemant @
MVV Å‘劷‹C—Ê Maximal Voluntary bVentilation @
My ‹ßŽ‹ Myopia @
Myelo Ò‘‘¢‰e Myelography @
£ã‚Ö–ß‚é
Copyright© 2006-2012.Hitori Gown Inc, All rights reserved.